Abstract
The michael adducts2a,b were obtained from the reaction of the phenylacetyl derivative1 with benzaldehyde and p-anisaldehyde respectively.2a and2b were subjected to react with cyanoethanoic acid hydrazide, malononitrile, cyanothioacetamide, cyanoacetamide and 1,1,3-tricyano-2-amino propene to yield4a-h and5a,b respectively. Hydrogen peroxide oxidation of2a,b gave the aurone derivative6a,b. The pyrone derivatives8a,b were obtained from2a,b by addition of chloroacetyl chloride followed by dehydrochlorination.
Similar content being viewed by others
References Cited
Anrep, G. V., Barsoum, G. S. and Kenawy, M. R., Pharmacological actions of the crystalline principles of Ammi visnaga.J. Pharm. Pharmac. 1, 164 (1949).
Beetz, T., Meuleman, D. G. and Wieringa, J. H., Inhibitors of blood platelet aggregation. Activity of some 1H-benz[de] isoquinoline car boximidamides on thein vivo blood platelet aggregation induced by collagen.J. Med. Chem., 25, 714 (1982).
Corell, T., Jensen, K. M. and Splwinski, J., Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs.Acta Pharmacol et Toxical, 45, 232 (1979).
El-Diwani, H. I., Nakkady, S. S., El-Shabrawy, O., Gohar, A. K. M. N. and Hishmat, O. H., Reactions of some cinnamoyl benzofuran derivatives with activiated nitriles and their biological activity.Arch. Pharm. Res., 11(1), 41–44 (1988).
Fauran, C., Raynaud, G., Eberle, J. and Pourrias, B., Hypotensive 5-cinnamoyl, benzofuran derivatives. (Delalande S.A.) Ger Offen, 1.933, 178 (1970);Chem. Abstr., 72, 100486 (1970).
Hardisty, R. M. Advanced Medicine, 16, 88 ed. by A. J. Bellingham), Pitman medical tunbridge wells (1980).
Hishmat, O. H., Abdel Rahman, A. H., Kandel, E. M. and Ismail, E. M., Reactions of hydroxybenzofurans. Syntheses of benzofuran chalcones, hydrazones and pyrazolines of potential biological activity.Drug Res., 27, 2035 (1977).
Hishmat, O. H., Abd El-Rahman, A. H., El-Diwani, H. I. and Abu Bakr, Sh. M., Synthesis of substituted furobenzopyrones.Indian J. of Chemistry, 26B, 566–568 (1987).
Ismall, I., Hishmat, O. H. and El-Diwani, H. I., Sensitivity of some reproductive pathogens to new benzofuran derivatives.Egyptian J. Vet. Scio., 22, 1, 1 (1985).
Ismall, E., Tawfik, A. A. and El Ebrashi, N. M. A., Antibacterial and anthelminthic properties of visnagnone and khellinone derivatives. Arzneim-Forsh, 27, 2 (1977).
Jain, N. C.,Schalm's Veterinary Haematology 4th ed Lee and Febiger, Philadelphia, 1986, VSA.
Kaneko, J. J. and Cornelius, C. E., Clinical Biochemistry of Domestic Animals, 2nd, Vol. 11, p. 194 (1971).
Lane, D. A., Scully, M. F., Thomas, D. P., Kakkar, V. V., Woolf, I. L. and Williams, R., Prolonged Thrombin clotting times in liver diseases.British J. of Haematology, 35, 301 (1977).
Lipinski, B., Lipinska, A. and Gurewich, V., Thrombin Time prolongation in cirrhosis in relation to enhanced fibrinogen degradation.J. Lab. and Clinic. Medicine, 90, 187 (1977).
Martinez, J. and Kwasniak, D., Abnormal sialic acid content of the dysfibrinagenemia associated with liver disease, 5th International congress on thrombosis and Haemostasis,Philadelphia, 38, 169 (1977).
Meier, R., Schular, W. and Desaulles, P., Zur Frage des Mechanismus der Hemmung des Bindegewebswachstums durch cortisone.Experimentia (Basel), 6, 469 (1950).
Nomura, T., Fukai, T., Uno, J. and Arait, T., Malberrofuran, A., A new isoprenoid 2-arylbenzofuran from the root bark of the cultivated mulberry tree (Morus alba L.),Heterocycles 9, 1593 (1978).
Weinstein, M. J. and Deykin, D., Quantitative abnormality of an Aα Chain molecular weight form in the fibrinogen of cirrhotic patients.J. Haematology, 40, 617 (1979).
Winter, C. A., Rislfy, E. A. and Nuss, G. W., Carrageenin induced deema in hind paww of the rat as an assay for anti-inflammatory drugs.Proc. Soc. Exp. Biol. Med., 111, 544 (1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hishmat, O.H., El-Diwani, H.I., Bakr, S.M.A. et al. Synthesis and pharmacological studies of some pyrone and benzodifuran derivatives. Arch. Pharm. Res. 16, 168–174 (1993). https://doi.org/10.1007/BF03036869
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03036869